These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 943290)

  • 1. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
    Costall B; Naylor RJ
    J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
    Neumeyer JL; Reinhard JF; Dafeldecker WP; Guarino J; Kosersky DS; Fuxe K; Agnati L
    J Med Chem; 1976 Jan; 19(1):25-9. PubMed ID: 942751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens.
    Kelly PH; Miller RJ; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):85-92. PubMed ID: 1253829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.
    Jackson EA; Neumeyer JL; Kelly PH
    Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors.
    Neumeyer JL; Reischig D; Arana GW; Campbell A; Baldessarini RJ; Kula NS; Watling KJ
    J Med Chem; 1983 Apr; 26(4):516-21. PubMed ID: 6682147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
    Neumeyer JL; Arana GW; Law SJ; Lamont JS; Kula NS; Baldessarini RJ
    J Med Chem; 1981 Dec; 24(12):1440-5. PubMed ID: 7310821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
    Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
    Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B; Naylor RJ; Neumeyer JL
    Eur J Pharmacol; 1975 Mar; 31(1):1-16. PubMed ID: 1168579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Biochem Pharmacol; 1995 May; 49(9):1185-93. PubMed ID: 7763300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
    Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.
    Campbell A; Baldessarini RJ; Neumeyer JL
    Psychopharmacology (Berl); 1993; 111(3):351-8. PubMed ID: 7870974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aporphines as antagonists of dopamine D-1 receptors.
    Schaus JM; Titus RD; Foreman MM; Mason NR; Truex LL
    J Med Chem; 1990 Feb; 33(2):600-7. PubMed ID: 2405158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms.
    Costall B; Fortune DH; Granchelli FE; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
    J Pharm Pharmacol; 1980 Aug; 32(8):571-6. PubMed ID: 6106696
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro.
    Arnt J; Hyttel J; Sánchez C
    Eur J Pharmacol; 1992 Mar; 213(2):259-67. PubMed ID: 1355737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat.
    Pifl C; Reither H; Hornykiewicz O
    Brain Res; 1992 Feb; 572(1-2):87-93. PubMed ID: 1535275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogs.
    Shen RS; Smith RV; Davis PJ; Abell CW
    J Biol Chem; 1984 Jul; 259(14):8994-9000. PubMed ID: 6746636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and potency comparisons among aporphine enantiomers: effects on dopamine neurons in substantia nigra of rat.
    Martin LP; Cox RF; Waszczak BL
    Neuropharmacology; 1990 Feb; 29(2):135-43. PubMed ID: 2184376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.